An article written by several faculty and staff members of the Indiana Clinical and Translational Sciences Institute (CTSI) was recently published in the Journal of Clinical and Translational Science.
The paper, titled Advancing medical technology innovation and clinical translation via a model of industry-enabled technical and educational support: Indiana Clinical and Translational Sciences Institute’s Medical Technology Advance Program, explains how the Indiana CTSI’s Medical Technology Advance Program (MTAP) provides technical and educational assistance to scientists looking to boost these aspects of their research.
In the paper, it is stated that the success rate for translation of newly engineered medical technologies into clinical practice is low. In order to increase the success rate, the Indiana CTSI developed MTAP.
Andrew Brightman, PhD, who is part of the leadership team of the Indiana CTSI based at Purdue University, is one of the authors of the paper. He says being published in a journal this large has helped to make other CTSAs across the country aware of the successes the MTAP has achieved in Indiana.
“We are pleased to have the information about MTAP published this year in the Journal of Clinical and Translational Science,” says Brightman. “It provides a key way to alert others about innovations in support processes and educational programs such as we have developed. Our goal was to bring attention to the needs for such technical and educational support for researchers who want to advance their medical technology innovations toward clinical implementation as well as to the integrated strategy that has been developed to meet those needs for the Indiana CTSI.”
The MTAP program is open to any researcher who would like assistance in getting their innovation utilized in clinical practice. For more information, please contact Kitty Cooper at kcooper@purdue.edu.
